151 related articles for article (PubMed ID: 32801256)
1. Expression analysis of aryl hydrocarbon receptor repressor (AHRR) gene in gallbladder cancer.
Kumar P; Yadav M; Verma K; Dixit R; Singh J; Tiwary SK; Narayan G; Dixit VK
Saudi J Gastroenterol; 2021; 27(1):54-59. PubMed ID: 32801256
[TBL] [Abstract][Full Text] [Related]
2. Poor prognosis of gastric adenocarcinoma with decreased expression of AHRR.
Li YF; Wang DD; Zhao BW; Wang W; Yuan SQ; Huang CY; Chen YM; Zheng Y; Keshari RP; Xia JC; Zhou ZW
PLoS One; 2012; 7(8):e43555. PubMed ID: 22952704
[TBL] [Abstract][Full Text] [Related]
3. Heterodimers of bHLH-PAS protein fragments derived from AhR, AhRR, and Arnt prepared by co-expression in Escherichia coli: characterization of their DNA binding activity and preparation of a DNA complex.
Kikuchi Y; Ohsawa S; Mimura J; Ema M; Takasaki C; Sogawa K; Fujii-Kuriyama Y
J Biochem; 2003 Jul; 134(1):83-90. PubMed ID: 12944374
[TBL] [Abstract][Full Text] [Related]
4. Characteristic expression of aryl hydrocarbon receptor repressor gene in human tissues: organ-specific distribution and variable induction patterns in mononuclear cells.
Yamamoto J; Ihara K; Nakayama H; Hikino S; Satoh K; Kubo N; Iida T; Fujii Y; Hara T
Life Sci; 2004 Jan; 74(8):1039-49. PubMed ID: 14672759
[TBL] [Abstract][Full Text] [Related]
5. Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes.
Jin Y; Möller E; Nord KH; Mandahl N; Von Steyern FV; Domanski HA; Mariño-Enríquez A; Magnusson L; Nilsson J; Sciot R; Fletcher CD; Debiec-Rychter M; Mertens F
Genes Chromosomes Cancer; 2012 May; 51(5):510-20. PubMed ID: 22337624
[TBL] [Abstract][Full Text] [Related]
6. Tissue distribution and function of the Aryl hydrocarbon receptor repressor (AhRR) in C57BL/6 and Aryl hydrocarbon receptor deficient mice.
Bernshausen T; Jux B; Esser C; Abel J; Fritsche E
Arch Toxicol; 2006 Apr; 80(4):206-11. PubMed ID: 16205913
[TBL] [Abstract][Full Text] [Related]
7. Regulatory interactions among three members of the vertebrate aryl hydrocarbon receptor family: AHR repressor, AHR1, and AHR2.
Karchner SI; Franks DG; Powell WH; Hahn ME
J Biol Chem; 2002 Mar; 277(9):6949-59. PubMed ID: 11742002
[TBL] [Abstract][Full Text] [Related]
8. The crystal structure of the AhRR-ARNT heterodimer reveals the structural basis of the repression of AhR-mediated transcription.
Sakurai S; Shimizu T; Ohto U
J Biol Chem; 2017 Oct; 292(43):17609-17616. PubMed ID: 28904176
[TBL] [Abstract][Full Text] [Related]
9. Effects of human blood levels of two PAH mixtures on the AHR signalling activation pathway and CYP1A1 and COMT target genes in granulosa non-tumor and granulosa tumor cell lines.
Zajda K; Ptak A; Rak A; Fiedor E; Grochowalski A; Milewicz T; Gregoraszczuk EL
Toxicology; 2017 Aug; 389():1-12. PubMed ID: 28710019
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide mapping and analysis of aryl hydrocarbon receptor (AHR)- and aryl hydrocarbon receptor repressor (AHRR)-binding sites in human breast cancer cells.
Yang SY; Ahmed S; Satheesh SV; Matthews J
Arch Toxicol; 2018 Jan; 92(1):225-240. PubMed ID: 28681081
[TBL] [Abstract][Full Text] [Related]
11. Primary structure and inducibility by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) of aryl hydrocarbon receptor repressor in a TCDD-sensitive and a TCDD-resistant rat strain.
Korkalainen M; Tuomisto J; Pohjanvirta R
Biochem Biophys Res Commun; 2004 Feb; 315(1):123-31. PubMed ID: 15013435
[TBL] [Abstract][Full Text] [Related]
12. Repression of aryl hydrocarbon receptor (AHR) signaling by AHR repressor: role of DNA binding and competition for AHR nuclear translocator.
Evans BR; Karchner SI; Allan LL; Pollenz RS; Tanguay RL; Jenny MJ; Sherr DH; Hahn ME
Mol Pharmacol; 2008 Feb; 73(2):387-98. PubMed ID: 18000031
[TBL] [Abstract][Full Text] [Related]
13. Primary structure and organ-specific expression of the rat aryl hydrocarbon receptor repressor gene.
Nishihashi H; Kanno Y; Tomuro K; Nakahama T; Inouye Y
Biol Pharm Bull; 2006 Apr; 29(4):640-7. PubMed ID: 16595894
[TBL] [Abstract][Full Text] [Related]
14. Expression of aryl hydrocarbon receptor repressor in normal human tissues and inducibility by polycyclic aromatic hydrocarbons in human tumor-derived cell lines.
Tsuchiya Y; Nakajima M; Itoh S; Iwanari M; Yokoi T
Toxicol Sci; 2003 Apr; 72(2):253-9. PubMed ID: 12655030
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the transcriptional regulation and molecular function of the aryl hydrocarbon receptor repressor in human cell lines.
Haarmann-Stemmann T; Bothe H; Kohli A; Sydlik U; Abel J; Fritsche E
Drug Metab Dispos; 2007 Dec; 35(12):2262-9. PubMed ID: 17890447
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Aryl Hydrocarbon Receptor Signaling Pathway in Breast Cancer Development.
Vogel CFA; Lazennec G; Kado SY; Dahlem C; He Y; Castaneda A; Ishihara Y; Vogeley C; Rossi A; Haarmann-Stemmann T; Jugan J; Mori H; Borowsky AD; La Merrill MA; Sweeney C
Front Immunol; 2021; 12():625346. PubMed ID: 33763068
[TBL] [Abstract][Full Text] [Related]
17. Aryl hydrocarbon receptor repressor and TiPARP (ARTD14) use similar, but also distinct mechanisms to repress aryl hydrocarbon receptor signaling.
MacPherson L; Ahmed S; Tamblyn L; Krutmann J; Förster I; Weighardt H; Matthews J
Int J Mol Sci; 2014 May; 15(5):7939-57. PubMed ID: 24806346
[TBL] [Abstract][Full Text] [Related]
18. Role of AHR, AHRR and ARNT in response to dioxin-like PCBs in Spaurus aurata.
Calò M; Licata P; Bitto A; Lo Cascio P; Interdonato M; Altavilla D
Environ Sci Pollut Res Int; 2014 Dec; 21(24):14226-31. PubMed ID: 25060310
[TBL] [Abstract][Full Text] [Related]
19. The effect of aryl hydrocarbon receptor ligands on the expression of AhR, AhRR, ARNT, Hif1alpha, CYP1A1 and NQO1 genes in rat liver.
Brauze D; Widerak M; Cwykiel J; Szyfter K; Baer-Dubowska W
Toxicol Lett; 2006 Dec; 167(3):212-20. PubMed ID: 17069994
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of cancer mortality by smoking-induced aryl hydrocarbon receptor repressor DNA hypomethylation in Japanese population: A long-term cohort study.
Tsuboi Y; Yamada H; Munetsuna E; Fujii R; Yamazaki M; Ando Y; Mizuno G; Hattori Y; Ishikawa H; Ohashi K; Hashimoto S; Hamajima N; Suzuki K
Cancer Epidemiol; 2022 Jun; 78():102162. PubMed ID: 35461154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
